Newsroom
Market News
Both sides of the trade, grades and news round-ups. Click a headline to read it — the arrows walk the list.
Research
- Cintas Corporation Faces Massive Pullback Amid Revenue In-Line
- Lennar Corporation's Disappointing Q4 2024 Earnings Call and Its Impact on Stock Prices
- Shareholders Encouraged to Join Class Action Against Zeta Global Holdings Corp.
- Chipotle Mexican Grill, Inc. Class Action Lawsuit Update
- Legal Firms Encourage MTCH Investors to Act before January 24
- Dow Jones ETF Faces Worst Losing Streak in 50 Years
- Class Action Filed Against Xerox Holdings Corporation (XRX)
- Investors in Evolv Technologies Holdings, Inc. (EVLV) Encouraged to Join Class Action Lawsuit
- Exciting Developments in Various Industries Unfold Across the Globe
- Conagra Brands Faces Stock Slide Due to Inflation Concerns
- Stock News: BioAge Labs, Inc. Investigated for Securities Law Violations
- Investor Alert: Rentokil Initial plc Faces Multiple Securities Fraud Lawsuits
- Lamb Weston Stock Plunges on Disappointing Q2 Earnings and Lowered Outlook
- Celsius Holdings, Inc. Securities Fraud Class Action Lawsuit Updates
- Nasdaq Stock News Update
- Legal Actions Against Visa Inc. Prompt Investor Reaction
- Stock Fraud Alert: DENTSPLY SIRONA Inc. Faces Class Action Lawsuits
- Securities Lawsuits Against The Toronto-Dominion Bank: Recovery Options for Investors
- ASP Isotopes Inc. Investors Urged to Take Action Before February 3, 2025
- Legal Actions Against Aehr Test Systems: What Investors Need to Know
- ASML Holding N.V. Faces Multiple Class Action Lawsuits for Securities Law Violations
- Kyverna Therapeutics, Inc. Securities Fraud Class Action Lawsuit Updates
- Gold Prices Remain Steady Amidst Market Uncertainties
- Class Action Lawsuit Alert for Five9, Inc. Shareholders
- Tesla Faces Turbulent Year as Stock Drops Amidst Market Decline
- Financial News Update: Lawsuits and Dividends Impact Banking Sector
- Annual J.P. Morgan Healthcare Conference 2025 Highlights: Embecta, Protagonist Therapeutics, Acadia Pharmaceuticals, Arcus...
- Darden Restaurants Stock Soars After Impressive Q2 2025 Results
- CarMax Reports Solid Q3 Earnings Despite Lower Car Prices
- Hasbro Inc. Faces Class Action Lawsuit from Shareholders
- Securities Class Action Filed Against Marqeta, Inc. Sparks Investor Alerts
- Nvidia's Future in the AI Chip Market: A Closer Look at Recent Developments
- Potential Recovery for Warner Bros. Discovery, Inc. (WBD) Investors
- Accenture CEO Discusses Government Cost Cuts and Q1 Earnings Beat
- Class Action Lawsuit Filed Against Wolfspeed, Inc. (NYSE: WOLF)
- Humacyte, Inc. Faces Multiple Class Action Lawsuits from Investors for Securities Violations
- NIKE, Inc. Q2 2025 Earnings Call Overview
- FedEx (FDX) Reports Q2 Earnings: Analysis of Key Metrics and Future Strategies
- Micron Technology Faces Sharp Drop in Stock Price Due to Weak Outlook
- Securities Fraud Lawsuits Filed Against PACS Group, Inc., Investors Encouraged to Take Action
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with